BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12817796)

  • 1. New insulins and quality of life.
    Iafusco D
    Acta Biomed; 2003; 74 Suppl 1():18-20. PubMed ID: 12817796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current aspects in therapy of insulin-dependent diabetes mellitus in children and adolescents].
    Schönle EJ
    Schweiz Med Wochenschr; 1990 Jan; 120(3):54-60. PubMed ID: 2405479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How self management therapy can improve quality of life for diabetic patients.
    Lombardo F; Salzano G; Messina MF; De Luca F
    Acta Biomed; 2003; 74 Suppl 1():26-8. PubMed ID: 12817798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance and administration methods in management of type 1 diabetes.
    Lombardo F; Salzano G; Messina MF; De Luca F
    Acta Biomed; 2005; 76 Suppl 3():66-9. PubMed ID: 16915802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premixed insulin treatment for type 2 diabetes: analogue or human?
    Garber AJ; Ligthelm R; Christiansen JS; Liebl A
    Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of children and adolescents with diabetes mellitus: personal experience].
    Dorchy H
    Rev Med Brux; 2005 Sep; 26(4):S246-54. PubMed ID: 16240870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of type 1 diabetes mellitus in children and adolescents].
    Dorchy H
    Rev Prat; 1996 Mar; 46(5):577-86. PubMed ID: 8815524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus.
    Danne T
    Clin Ther; 2007; 29 Suppl D():S145-52. PubMed ID: 18191066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
    O'Neil KJ; Jonnalagadda SS; Hopkins BL; Kicklighter JR
    J Am Diet Assoc; 2005 Jan; 105(1):85-91. PubMed ID: 15635351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summer camps and quality of life in children and adolescents with type 1 diabetes.
    Mancuso M; Caruso-Nicoletti M
    Acta Biomed; 2003; 74 Suppl 1():35-7. PubMed ID: 12817801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closing the gap between literature and practice: evaluation of a teaching programme (in the absence of a structured treatment) on both type 1 and type 2 diabetes.
    Matteucci E; Giampietro O
    Diabetes Nutr Metab; 2003; 16(5-6):298-305. PubMed ID: 15000441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of insulin glargine and nutritional model on metabolic control, quality of life and behavior in children and adolescents with type 1 diabetes mellitus.
    Goksen D; Darcan S; Buyukinan M; Köse T; Erermis S; Coker M
    Acta Diabetol; 2008 Mar; 45(1):47-52. PubMed ID: 17928940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update on new insulins].
    Philips JC; Radermecker R
    Rev Med Suisse; 2005 Aug; 1(30):1936-8, 1940-1. PubMed ID: 16200936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. People with type 1 diabetes using short acting analogue insulins are less dehydrated than those with using human soluble insulin prior to onset of diabetic ketoacidosis.
    Dhatariya K
    Med Hypotheses; 2008 Nov; 71(5):706-8. PubMed ID: 18694627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
    Tan CY; Wilson DM; Buckingham B
    Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The new insulins].
    Krzentowski G
    Rev Med Brux; 2005 Sep; 26(4):S241-5. PubMed ID: 16240869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.